Bartlett & Co’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bartlett & Co’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$134K	Hold	700	–	–	﹤0.01%	535
2023 Q3	$139K	Sell	700 -12	-2%	-$2.84K	﹤0.01%	496
2023 Q2	$203K	Hold	712	–	–	﹤0.01%	451
2023 Q1	$154K	Buy	712 +100	+16%	+$19.5K	﹤0.01%	411
2022 Q4	$126K	Hold	612	–	–	﹤0.01%	441
2022 Q3	$170K	Hold	612	–	–	﹤0.01%	396
2022 Q2	$117K	Buy	612 +12	+2%	+$2.12K	﹤0.01%	442
2022 Q1	$124K	Buy	+600	New	+$98.9K	﹤0.01%	449
2021 Q4	–	Sell	-500	Closed	-$103K	–	921
2021 Q3	$103K	Sell	500 -100	-17%	-$19.6K	﹤0.01%	410
2021 Q2	$114K	Sell	600 -600	-50%	-$98.2K	﹤0.01%	392
2021 Q1	$156K	Hold	1,200	–	–	﹤0.01%	348
2020 Q4	$124K	Hold	1,200	–	–	﹤0.01%	381
2020 Q3	$91K	Buy	+1,200	New	+$68K	﹤0.01%	397

Other funds holding SWAV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bartlett & Co's SWAV Position: Q4 2023 in Review

Bartlett & Co held its Shockwave Medical, Inc. Common Stock (SWAV) position steady in Q4 2023 at 700 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #535.

Bartlett & Co first reported a position in SWAV in Q3 2020 and has held it in 13 quarters since. The position peaked at $203K in Q2 2023. 427 funds tracked by Wall St. Rank hold SWAV as of Q4 2023.

Bartlett & Co held 700 shares of Shockwave Medical, Inc. Common Stock worth $134K as of Q4 2023.
Bartlett & Co left its Shockwave Medical, Inc. Common Stock share count unchanged in Q4 2023.
Shockwave Medical, Inc. Common Stock made up ﹤0.01% of Bartlett & Co's portfolio in Q4 2023, its #535 holding.
Bartlett & Co first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2020 and has held it in 13 quarters since.
Bartlett & Co's Shockwave Medical, Inc. Common Stock position peaked at $203K in Q2 2023.
427 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2023.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.